Search research articles
Contact Us
Filters
Showing results (791-800 of 832) with videos related to
Page
of 84
Sort By:
The Journal of Infectious Diseases
|
June 18, 2026
Cerebrospinal fluid transcriptional immune pathways linked to survival in HIV-associated tuberculous meningitis
Martineau Louine, Ravi Dandekar, Sumanth P Reddy, et al.
Journal of Clinical Medicine
|
October 14, 2022
Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
Nicolas Hoertel, Marina Sánchez-Rico, Johannes Kornhuber, et al.
JAMA
|
February 22, 2023
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial
Susanna Naggie, David R Boulware, Christopher J Lindsell, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 4, 2020
Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19
Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
JAMA Internal Medicine
|
July 14, 2025
Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 1, 2025
Metformin on Time to Sustained Recovery in Adults with COVID-19: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
The Lancet. Infectious Diseases
|
January 31, 2026
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial
Scott K Heysell, Stellah G Mpagama, Edwin Nuwagira, et al.
Open Forum Infectious Diseases
|
November 18, 2020
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19
Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
Journal of the International AIDS Society
|
June 6, 2025
Household economic impact of HIV-associated cryptococcal meningitis in five countries in Southern and Eastern Africa
David S Lawrence, Charles Muthoga, Jack Adams, et al.
Nature Communications
|
March 31, 2022
Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics
P S Ramachandran, A Ramesh, F V Creswell, et al.
Page
of 84
Search research articles
Search
Showing results (791-800 of 832) with videos related to
Sort By:
Page
of 84
The Journal of Infectious Diseases
|
June 18, 2026
Cerebrospinal fluid transcriptional immune pathways linked to survival in HIV-associated tuberculous meningitis
Martineau Louine, Ravi Dandekar, Sumanth P Reddy, et al.
Journal of Clinical Medicine
|
October 14, 2022
Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
Nicolas Hoertel, Marina Sánchez-Rico, Johannes Kornhuber, et al.
JAMA
|
February 22, 2023
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial
Susanna Naggie, David R Boulware, Christopher J Lindsell, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 4, 2020
Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19
Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
JAMA Internal Medicine
|
July 14, 2025
Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 1, 2025
Metformin on Time to Sustained Recovery in Adults with COVID-19: The ACTIV-6 Randomized Clinical Trial
Carolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
The Lancet. Infectious Diseases
|
January 31, 2026
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial
Scott K Heysell, Stellah G Mpagama, Edwin Nuwagira, et al.
Open Forum Infectious Diseases
|
November 18, 2020
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19
Sarah M Lofgren, Melanie R Nicol, Ananta S Bangdiwala, et al.
Journal of the International AIDS Society
|
June 6, 2025
Household economic impact of HIV-associated cryptococcal meningitis in five countries in Southern and Eastern Africa
David S Lawrence, Charles Muthoga, Jack Adams, et al.
Nature Communications
|
March 31, 2022
Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics
P S Ramachandran, A Ramesh, F V Creswell, et al.
Page
of 84